The recent past and near future of drug approvals in Europe
19 Jun 2017
The recent past and near future of drug approvals in Europe
ASCO 2017: Round up
Editor's Choice for April 2017
Positive lessons of negative trials
ESMO 2016 conference highlights
Risk of serious and fatal adverse events with sorafenib use in patients with solid cancers